The first large-scale trials of two Ebola vaccines began in Liberia on Monday, the hospital hosting the research said. The vaccines, which contain harmless elements of the killer virus that trigger an immune response, were administered to 12 volunteers at the start of a trial which will eventually involve up to 27,000 adults. "We received 20 persons who came voluntarily to take the vaccine but we are taking only 12 per day," said Melvin Johnson, head of the trial centre at the Redemption Hospital in the capital Monrovia. The Partnership for Research on Ebola Vaccines in Liberia (PREVAIL), a collaboration between the United States and Liberia, said trials would begin at other hospitals around Monrovia after the first 600 participants join the study.
via Health News Headlines - Yahoo News http://ift.tt/1yu1Wzz
No comments:
Post a Comment